home / stock / cdmo / cdmo quote
Last: | $9.59 |
---|---|
Change Percent: | -0.53% |
Open: | $9.5 |
Close: | $9.59 |
High: | $9.89 |
Low: | $9.02 |
Volume: | 1,827,081 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.59 | $9.5 | $9.59 | $9.89 | $9.02 | 1,827,081 | 07-22-2024 |
$9.45 | $9.51 | $9.45 | $9.65 | $9.22 | 1,052,930 | 07-19-2024 |
$9.5 | $9.77 | $9.5 | $9.93 | $9.44 | 2,024,751 | 07-18-2024 |
$9.77 | $9.5 | $9.77 | $10.01 | $9.33 | 1,503,470 | 07-17-2024 |
$9.53 | $8.42 | $9.53 | $9.57 | $8.42 | 2,340,129 | 07-16-2024 |
$8.32 | $8.4 | $8.32 | $8.69 | $8.29 | 1,205,275 | 07-15-2024 |
$8.32 | $8.05 | $8.32 | $8.55 | $8.05 | 1,258,377 | 07-12-2024 |
$8 | $7.54 | $8 | $8.35 | $7.49 | 1,529,153 | 07-11-2024 |
$7.39 | $7.54 | $7.39 | $7.74 | $7.22 | 521,726 | 07-10-2024 |
$7.58 | $7.14 | $7.58 | $7.74 | $6.85 | 1,113,431 | 07-09-2024 |
$7.17 | $7.43 | $7.17 | $7.56 | $7.12 | 571,098 | 07-08-2024 |
$7.42 | $7.64 | $7.42 | $7.72 | $7.38 | 827,699 | 07-05-2024 |
$7.7 | $6.7 | $7.7 | $7.88 | $6.61 | 1,447,392 | 07-04-2024 |
$7.7 | $6.7 | $7.7 | $7.88 | $6.61 | 1,447,392 | 07-03-2024 |
$6.7 | $7.18 | $6.7 | $7.18 | $6.62 | 774,370 | 07-02-2024 |
$7.12 | $7.14 | $7.12 | $7.29 | $6.9 | 1,276,247 | 07-01-2024 |
$7.14 | $7.01 | $7.14 | $7.2899 | $6.86 | 1,022,074 | 06-28-2024 |
$7.01 | $7.21 | $7.01 | $7.21 | $6.785 | 405,404 | 06-27-2024 |
$7.01 | $7.14 | $7.01 | $7.14 | $6.71 | 921,343 | 06-26-2024 |
$7.1 | $7.14 | $7.1 | $7.23 | $7.02 | 558,584 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...